Cellsonics

Enzyme-free, easily obtainable single cells & nucleic acids from solid tissue

Image-empty-state_edited.jpg
INVESTMENt

June, 2019

location

Northern California, CA, USA

Sector

Science

co-investors

Vertical Venture Partners

Founder

Steve Levers, Co-Founder & CEO

Cellsonics is revolutionizing single-cell sample preparation, delivering the individual characteristics of each sample for a precision medicine approach to the analysis, treatment, and diagnosis of disease. The company has developed tools to process single cells and nucleic acids from the solid tissue without compromising the gene expression data.